Jonie’s practice focuses on capital markets transactions and general corporate and securities matters. She represents investment banks and issuers on a variety of securities offerings, including initial public offerings, secondary and follow-on offerings, direct listings, and debt offerings, particularly in the technology and life sciences industries. Jonie also advises public companies on corporate and securities matters, including reporting obligations and corporate governance.

Download full bio 


  • Ascendis Pharma – $460 Million Follow-On Offering 

  • LegalZoom – $705.7 million IPO and Concurrent Private Placement 

  • Day One Biopharmaceuticals – $184 Million IPO 

  • Biomea Fusion – $153 Million IPO 

  • Angion Biomedica – $92 Million IPO 

  • View all


  • University of Pennsylvania Law School
    JD, cum laude, 2007

  • University of California, Berkeley
    BA, 2002

Admissions & Credentials


Rankings & Accolades

    Chambers USA: Up and Coming – Capital Markets: Debt & Equity (California and Nationwide – Western United States) (2021-2022)